Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function
- 6.7k Downloads
The HIV Rev protein is known to facilitate export of incompletely spliced and unspliced viral transcripts to the cytoplasm, a necessary step in virus life cycle. The Rev-mediated nucleo-cytoplasmic transport of nascent viral transcripts, dependents on interaction of Rev with the RRE RNA structural element present in the target RNAs. The C-terminal variant of dsRNA-binding nuclear protein 90 (NF90ctv) has been shown to markedly attenuate viral replication in stably transduced HIV-1 target cell line. Here we examined a mechanism of interference of viral life cycle involving Rev-NF90ctv interaction.
Since Rev:RRE complex formations depend on protein:RNA and protein:protein interactions, we investigated whether the expression of NF90ctv might interfere with Rev-mediated export of RRE-containing transcripts. When HeLa cells expressed both NF90ctv and Rev protein, we observed that NF90ctv inhibited the Rev-mediated RNA transport. In particular, three regions of NF90ctv protein are involved in blocking Rev function. Moreover, interaction of NF90ctv with the RRE RNA resulted in the expression of a reporter protein coding sequences linked to the RRE structure. Moreover, Rev influenced the subcellular localization of NF90ctv, and this process is leptomycin B sensitive.
The dsRNA binding protein, NF90ctv competes with HIV Rev function at two levels, by competitive protein:protein interaction involving Rev binding to specific domains of NF90ctv, as well as by its binding to the RRE-RNA structure. Our results are consistent with a model of Rev-mediated HIV-1 RNA export that envisions Rev-multimerization, a process interrupted by NF90ctv.
KeywordsNuclear Export Signal Nuclear Localization Signal Domain dsRNA Binding Motif Nuclear Export Signal Region Nuclear Export Signal Domain
Upon entering an uninfected host cell, the single-stranded RNA genome of Human immunodeficiency virus type 1 (HIV-1) is copied into DNA by the viral reverse transcriptase. Following integration of DNA into the host genome, transcriptional activation of the proviral DNA generates progeny virions. The post-integration events of transcription, RNA splicing, transport and translation of viral mRNAs are regulated by coordinate interaction with host proteins . Strict dependence of viral gene expression on host factors particularly those with protein:RNA and protein:protein binding properties, are useful targets to explore novel antiviral therapy.
Regulation of HIV-1 gene expression is controlled mainly by the two virus encoded proteins, Tat responsible for processive transcription elongation, and Rev which regulates transport of unspliced and incompletely spliced viral transcripts from the nucleus to the cytoplasm. These two regulatory proteins function by binding to structured RNA domains present in the viral transcripts, the trans-activation responsive RNA (TAR) and the Rev response element (RRE) respectively.
The functional domains of Rev include an N-terminal nuclear localization signal (NLS) rich in Arg-residues, and a C-terminal nuclear export signal (NES) rich in Leu-residues. The NES of Rev interacts with host proteins that are critical for RNA export, and the NLS binds to the RRE-RNA structure, and is also involved in Rev-homodimerization [2, 3, 4]. After dissociation from RRE in the cytoplasm, the NLS of Rev binds to importin-β (Imp-β), allowing its import back into the nucleus. Once in the nucleus, Rev interacts with the RRE RNA present in the incompletely spliced and unspliced viral transcripts. The newly formed Rev:RRE complex recruits proteins such as Crm1  or eIF5A  that are essential cofactors in regulating nuclear export [5, 6]. Interaction of Rev with Crm1 occurs via the NES present in both proteins  a process inhibited by the leptomycin B (LMB). The NES domains play a critical role in the intracellular localization of viral and cellular proteins [8, 9, 10].
The Rev:RRE:Crm1 complex is translocated through the nuclear pore complex to the cytoplasm. This translocation is dependant on the RNA helicase activity of DDX3, which binds to the Rev:RRE:Crm1 complex on the nuclear side of the Nuclear Pore Complex and accompanies it through to the cytoplasmic side [11, 12]. After dissociation, the viral transcripts are recognized by the translation machinery for synthesis of viral structural proteins .
In murine fibroblast A9 cells, export of HIV-1 transcripts mediated by Rev is restricted due to as yet unidentified host cell factor(s) that block Rev-mediated transport. However the Rex protein, an analogue of Rev encoded by the Human T cell leukemia virus type 1 (HTLV-1) is able to mediate RNA transport in murine cells. Marques et al.  reported that a chimeric protein containing the N-terminal region of Rev (amino acids 1–79) comprising the NLS, and the C-terminal region of Rex (amino acids 79–95) comprising the NES region of Rex, restored Rev-mediated RNA transport in A9 cells, suggesting that a putative murine cell inhibitor of Rev-function might recognize NES domain of Rev.
NF90 is encoded by the ilf-3 gene, which by alternative splicing [14, 15] gives rise to a family of double stranded RNA binding domain(DRBD) proteins that include NF90, NF110, MPP4 90, MPP4 110, ILF-3, NFAR-1 and NFAR-2, which are implicated in different functions such as transcription, RNA splicing, RNA editing and export. It is unclear if any of the DRBD proteins directly influence Rev-dependent RNA transport.
We studied a unique form of NF90, designated NF90ctv . The C-terminal variant, NF90ctv is distinct from other proteins encoded by ilf-3 in that its C-terminal 67 amino acids (Fig. 1) is Arg-Gly-poor (RG-), whereas the corresponding C-terminal region is Arg-Gly-rich (RG+) in all the other proteins of this family. NF90 is predominantly a nuclear protein. In interphase cells however, about half of the NF90 is tethered in the nucleus by RNA bound to protein with dsRNA-dinding motif, while in mitosis NF90 is phosphorylated and translocated to the cytoplasm, without loss of its affinity for dsRNA . It has been reported that NF90 in the cytoplasm can stabilize the IL-2 mRNA by binding to its AU-rich elements . Moreover, its presence in complexes with the 3' untranslated region (UTR) of Tau mRNA  indicates that NF90 is part of the protein complex that interacts with the Tau mRNA, and is essential for its exonal translocation. Thus the NF90 family of proteins, due largely to their dsRNA recognition function, may affect gene expression by targeted localization of structured RNA molecules.
Among the proteins encoded by the ilf-3 gene, NF90/NFAR's proteins have been reported to serve as substrate for PKR . NF90 protein has characteristics analogous to those of interferon (IFN) type 1  such as the capacity to activate genes involved in defense against viral infection. NF90 was originally reported to be a transcription factor, although it does not possess DNA binding domains . NF90 can negatively or positively regulate expression of a reporter gene, depending on the viral promoter used . The report that NF90ctv arrests HIV-1 replication in human osteosarcoma-derived cells , supports the argument that ectopic expression of NF90ctv results in overall stimulation of IFN response genes.
We reason that the attenuation of HIV-1 replication in NF90ctv expressing cells may in part be due to the affinity of NF90ctv protein to the structured RNA molecules essential in viral life cycle. That is, in addition to generalized induction of the innate antiviral response pathway in NF90ctv-expressing cells , the binding properties of NF90ctv to structured RNAs are likely to interfere with specific steps of viral life cycle, particularly those that rely on precise protein:RNA interactions. Thus, the overall antiviral response of NF90ctv may result from the stimulated innate immunity of the host following virus infection as well as from the ability of NF90ctv to interfere with specific steps in the viral life cycle. Here we examined the protein:protein and protein-dsRNA interaction properties of NF90ctv that inhibits HIV-1 replication by blocking Rev function. The results suggest that NF90ctv negatively affects the export of HIV-1 transcripts regulated by Rev. The NF90ctv-mediated inhibition of Rev involved three specific regions of NF90ctv protein.
NF90ctv inhibits Rev-dependent CAT activity
Next we characterized specific region(s) of NF90ctv (Fig. 1B) implicated in inhibition of Rev function. The 5'- or the 3'-regions of the NF90ctv coding sequence were cloned separately into the pCI-neo vector and the resulting constructs were used to transfect HeLa cells in the presence of the reporter pCMV128 and the Rev expression vector, pRSV/Rev. Both the N-terminal and the C-terminal regions of NF90ctv inhibited Rev function (Fig. 2, lanes 4 and 5, respectively), suggesting that at least two regions of NF90ctv contain sequences that affect the Rev function.
As outlined (Fig. 1B), two dsRNA binding motifs (DRBD 1 and DRBD 2) are located in the C-terminal half of NF90ctv, where as the N-terminal region of NF90ctv may be involved in protein-protein interactions. By comparison with other proteins in the NF90 family, the N-terminal half of NF90ctv contains an NES region (Fig. 1B), and its C-terminal 67 amino acid sequence is deficient in arginine/glycine residues (RG-). To evaluate the influence of specific NF90ctv domains on Rev-dependent CAT activity, the NES, DRBD 1, DRBD 2 and RG- coding regions were cloned into the pCI-neo vector (Fig. 1C), and used in cotransfection experiments in the presence of CAT-RRE reporter, pCMV128 and the Rev expression vector, pRSV/Rev. We first verified that the NES, DRBD 2 and RG- fragments without NLS, translocate to the nucleus. Indeed, when these NF90 protein domains were cloned into the fluorescent tagged vector, pmRFP and expressed as fusion proteins, they were observed in the cytoplasm as well as in the nucleus (data not shown).
As shown in Figure 2, the NES, DRBD 2 and RG- regions inhibited the Rev dependent CAT activity (lanes 6–8 and 10 respectively); DRBD 1 effect was less pronounced (lane 10); however, RG- showed a higher inhibitory effect on Rev-mediated RNA export. These results suggest that three regions of NF90ctv, the NES, DRBD 2 and RG-, are involved in blocking Rev function, and collectively they would strongly interfere with Rev function, possibly involving protein:protein or protein:RNA interactions. Results similar to those presented in Figure 2 were obtained with three independent transfection assays with each of the NF90ctv domains. In control experiments, using the empty pCI-neo vector, there was no induction of the CAT reporter gene with or without Rev (data not shown).
NF90 interact with REV protein
The N-terminus of NF90ctv protein includes a region that is likely to be involved in protein:protein interactions . In addition, its C-terminal RG- domain includes three SH3 motifs (PXXP) that are known to be important in certain protein:protein interactions [28, 29]. Hence a possible mechanism of NF90ctv-mediated inhibition of Rev function may include sequestration of Rev involving NF90ctv:Rev protein interaction. We tested the possibility by co-expressing Rev and NF90ctv in HeLa cells transfected with pRSV/Rev or pOZ-Flag/NF90. We assessed the expression of two proteins by Western blotting, using α-Rev31–50 and anti-FLAG antibodies. Results showed that both Rev and NF90ctv proteins are expressed in HeLa cells (data not shown).
The RG- region of NF90ctv is involved in interaction with Rev
The C-terminal 67 amino acids (604–671) of NF90ctv designated RG-, possess three SH3 motifs, that appear to be involved in protein:protein interactions . This region of NF90ctv was cloned into pGEX-4T-3 leading to pGST/RG- that is expected to yield a recombinant GST/RG- protein of ~33 kDa. The protein expressed in E. coli was purified by affinity chromatography and analyzed by Western blotting using either a polyclonal α-GST/RG- or α-GST antibodies. With both types of antibodies, a protein band migrating at the level of the recombinant GST/RG- protein was detected. No ~33 kDa band appeared in similar Western blots with preimmune sera (data not shown).
The purified GST/RG- protein was used to study the interaction of the RG- domain of NF90ctv with Rev. It was coupled to a glutathione-Sepharose 4B column, and used in pull-down assays by adding extracts from HeLa cells that express Rev, or with purified Rev protein. After washing to remove unbound proteins, possible Rev:RG- complexes were eluted, resolved by SDS-PAGE and visualized by Coomassie blue staining. As shown in Figure 4 lane 4, when extract from HeLa cells expressing Rev was added to the glutathione-Sepharose column, an additional band of ~25 kDa corresponding to Rev protein was detected. This band was absent from control samples, i.e. lysates from IPTG-induced E. coli cells (lane 1), or from uninduced (lane 2) E. coli cells or with extracts from untransfected HeLa cells (lane 3). Similar results were obtained when purified Rev expressed in E. coli replaced the HeLa cell extracts previously transfected with pRSV/Rev (lane 5). It should be noted that in all cases a double band of about 33 kDa was observed for GST/RG- but only the faster-migrating band was recognized by the α-GST/RG- or α-GST (Amersham) antibodies. The results indicate that the RG- region of NF90ctv is involved in direct interaction with Rev, in agreement with the results obtained by immunoprecipitation of full length NF90ctv (Fig. 3, lane 1).
NF90ctv and Rev show similar subcellular localization
Interestingly, in the case of HeLa cells co-transfected with pGFP/NF90 + pRev/mRFP in the presence of LMB, Rev was concentrated entirely in the nucleolus, whereas NF90 was present both in the nucleus and in the nucleolus (Fig. 5d'–d'''), mostly in the nucleolus.
NF90ctv influences the expression of gene linked to RRE structure
The space of interactions between viral and host elements is complex, and our understanding of these dynamics is incomplete. In this study we explored whether the NF90ctv-mediated inhibition of HIV-1 Rev involved Rev-NF90ctv interaction. The results presented here show that NF90ctv inhibits the Rev mediated export of viral RNA. To refine this observation, and study its molecular mechanisms, we created a series of vectors containing segments of the NF90ctv gene to use in transfection studies. We investigated the possibility that specific regions of NF90ctv may be involved in blocking Rev-mediated RNA export activity, by expressing the NF90ctv regions in HeLa cells. Three regions of NF90ctv in particular diminished Rev function, the NES, DRBD 2 and the C-terminal RG-.
The region of NF90ctv with the greatest inhibition of Rev function, the RG- domain, consists of the C-terminal 67 amino acids. This domain contains three SH3 motifs that are rich in Pro, which has been described to be involved in protein:protein interactions . SH3 motifs are highly conserved and are present in many proteins that interact with RNAs. We suggest that the SH3 motifs of NF90ctv may be involved in the Rev:NF90ctv interaction to block Rev function.
In addition, studies have indicated that NF90 possesses several regions capable of protein:protein interactions; including PKR [32, 33], NF45 , and eIF-2 . Protein motifs capable of interacting with dsRNAs can also participate in protein:protein interactions, such as homodimerization, as in the case of Rev. The active homodimers of Rev protein form complexes with the RRE structure [34, 35]. Proteins with dsRNA binding motifs can also interact with dsRNA ligands bound to proteins implicated in innate immunity and defence against viral infections, such as PKR [36, 37]. The detailed elucidation these interactions will be required to understand the dynamics of viral – host interactions.
However, since NF90ctv contains two dsRNA binding motifs, a direct interaction between NF90ctv and the HIV-1 RRE RNA structure may be equally important in blocking Rev function. These two DRBDs bind to the small and highly structured human Adenovirus transcript designated Adeno-associated virus RNA , to the highly conserved encapsidation signal ε of the Hepatitis B pregenomic RNA , and also to the 3' UTR of Tau mRNA . We investigated whether NF90ctv could bind the RRE structure. Our results suggest that NF90ctv is able to bind to RRE, leading to the expression of the protein coding sequence linked to the RRE-RNA structure. Our results suggest that interaction between NF90ctv and Rev protein (Fig 7c), as well as direct interaction between NF90ctv and RRE RNA structure may affect RNA export from the nucleus (Fig. 7b). We suggest that competition between NF90ctv and Rev for RRE binding could in part explain the decrease of Gag expression. However, the overall molecular mechanisms of NF90ctv mediated antiviral response will require further studies.
Rev protein has been reported to reside mainly in the nucleus , and is translocated to cytoplasm in presence of RRE (Fig. 6a and Fig. 7a). Rev shuttles between the nucleus and cytoplasm, since it harbours the NLS domain that interacts with Importin β. The NES domain of Rev is recognized by Crm1/exportin 1 . Substitution of Rev and RRE by an export promoting sequence construct, RTE m26 – CTE, produces infectious virus , suggesting that export is indeed a primary function of Rev:RRE. Similar to Rev, NF90 has been described mainly in the nucleus yet, it can shuttle between the nucleus and the cytoplasm due to its NES and NLS motifs . When NF90ctv is expressed in presence of RRE RNA structure (GFP-RRE), it is tethered in the nucleus, whereas mRNA linked to RRE would normally be exported to the cytoplasm.
Overall, the results are consistent with a mechanism of inhibition of Rev based on the interaction of Rev protein with specific domains of NF90ctv. The Rev-NF90ctv interaction may prevent Rev homodimer formation, an essential step in interaction of Rev with RRE. For the export of unspliced or incompletely spliced transcripts to be efficient, Rev must be imported back into the nucleus where it must reach a specific concentration  to induce complex formation with the RRE. The transdominant Rev mutant, RevM10, that inhibits Rev activity , is restricted to the nucleus and competes with Rev for interaction with the RRE. Rev-dependent export has been reported to be specifically inhibited by LMB  which prevents the interaction between Rev and Crm1. Likewise Sam68ΔC, (i.e. the cell protein Sam68 devoid of its C-terminal domain), inhibits Rev activity, thereby preventing the transcripts from entering the translation machinery . The authors conclude that Sam68ΔC leads to perinuclear accumulation of the unspliced or incompletely spliced mRNAs of HIV-1.
The results described here suggest a novel means of inhibition of HIV-1 Rev function based on direct interaction between NF90ctv and Rev, interfering with the export activity of Rev (Fig. 7). To our knowledge, no cellular protein has to date been reported to have such an effect. The antiretroviral compounds presently in use may be of limited use due to emerging drug resistant viral strains. Results described here open the possibility of exploring novel therapeutic approaches against HIV-1/AIDS, based on NF90-mediated inhibition of Rev.
Constructs and plasmids
The pEFX90 vector harboring the entire human NF90 coding sequence was kindly provided by P. N. Kao (Stanford Univ., Calif.). To produce Flag/NF90, the NF90 coding sequence was recovered from pEFX90 by NcoI digestion and subcloned into the pUC18 vector upstream of and in-frame with the Flag-coding sequence. The Flag/NF90 coding sequence was then excised by NsiI and MscI digestion and ligated into the pOZ vector kindly provided by Dr. B. Howard (NIH) and previously cleaved by XhoI and NsiI, yielding the pOZ-Flag/NF90.
Primers used to amplify regions of NF90ctv by PCR for cloning into the pCI-neo vector.
pCI-neo/DRBD 1 NF90
pCI-neo/DRBD 2 NF90
The pcsRev/GFP was kindly provided by Dr. George Pavlakis (National Cancer Institute, Frederick, Md). The reporter plasmid pCMV128 (provided by Dr. Thomas J. Hope, Northwestern University, Chicago) carries the second intron of HIV-1 with the RRE structure downstream of the CAT coding sequence (Fig. 1A) and therefore the expression of CAT strictly depends on Rev:RRE interaction for export of the CAT coding sequence . pRSV/Rev that expresses Rev was kindly provided by Dr. T. J. Hope; the pSGT-5(SDM/RRE/CM-GFP) was kindly provided by Dr. S. Arya (NCI/NIH) and contains the HIV-1 Gag gene and the GFP gene linked to HIV RRE structure. The GFP-coding pEGFP-N1 was from Clontech.
To obtain the pRev/mRFP construct that expresses the monomeric red fluorescent protein (mRFP), the following strategy was used. The mRFP cassette was amplified from pcDNA3 (kindly provided by R. Y. Tsien, University of California, San Diego) using the 5'primer GGATCCGCGGCAGACCATGGCTAGCA and the 3'primer GCGGCCGCTTAGGCGCCGGTGGAGTG. The 5'primer presents a BamHI site (underlined) and a Kozak sequence, and the 3'primer a NotI site (underlined). On the other hand, pEGF-N1, which expresses the GFP, was cleaved with BamHI and NotI to delete the EGFP cassette, and replaced it by the mRFP PCR product to obtain the pmRFP construct used to transform Escherichia coli DH5α. Rev was amplified from pRSV/Rev using the 5'primer GAATTCTGCCGCCACCATGGCAGGAAGAAGCGGA (EcoRI underlined) and the 3'primer CCCGGGTTCTTTAGCTCCTGACTCCAA (SmaI underlined). The PCR product was digested with EcoRI/SmaI and ligated into pmRFP previously digested with the same enzymes to obtain the pRev/mRFP construct.
To introduce the RG- region of NF90ctv (Fig. 1C) into pGEX-4T-3 (Amershan), the corresponding region was released from pCI-neo/RG- NF90 using EcoRI/SmaI and cloned into pGEX-4T-3, yielding pGST/RG- that codes for the GST/RG- protein.
Cell culture and transfection
A human osteosarcoma cell line stably transduced with CD4 and CXCR4, a T-tropic HIV-1 target cell line (GHOST/CD4+/CXCR4+), was maintained as described  except that fetal bovine serum was from Invitrogen, or from Vecol, Colombia. Cells were plated at ~3 × 105 cells per 35 mm-diameter dish 24 h before transfection with 2 μg each of the appropriate plasmid DNA using Superfect (Qiagen) following the manufacturer's instructions. Cells were harvested 24 or 48 h after transfection and lysed as described . The protein concentration of lysates was determined by the Bradford assay (Bio-Rad).
To evaluate expression of Rev and Flag/NF90 following co-transfection with pRSV/Rev and pOZ-Flag/NF90, cell extracts were analyzed by SDS-PAGE, the proteins transferred to a polyvinylidene-difluoride membrane (PVDF; Bio-Rad), and immunodetected with α-Rev31–50 or α-Rev71–90 antibodies (generously supplied by S. Marques, George Washington University), or α-Flag antibodies (Sigma).
HeLa cells were co-transfected with the plasmid constructs outlined in Table 1. To normalize transfection efficiency, the pEGFP-N1 control plasmid was included in each transfection assay. Cell lysates containing equal amounts of protein were used in the CAT assays performed as previously described . The results are presented as fold increase or decrease in CAT activity measured as chloramphenicol acetylation normalized proteins from cells transfected with the pCMV128 reporter plasmid alone or the pCI-neo empty expression vector for NF90 as negative control.
Immunoprecipitation and immunoblot analysis
For the immunoprecipitation assays, 4 × 105 HeLa cells were grown to about 80% confluence and cotransfected with 1.5 μg each of pRSV/Rev and pOZ-Flag/NF90, and after 24 h extracts were prepared as described above. Cell extracts (35 μl) were preincubated overnight at 4°C with 5 μl of α-Flag antibodies with gentle shaking. Protein A agarose (10 μl; Invitrogen) was then added and incubation continued for 3 h. The precipitate was recovered by centrifugation, washed 3 times in PBS 1× and the resin suspended in 20 μl of 4 × Laemmli buffer. The protein suspension was analyzed by SDS-PAGE, transferred to a PVDF membrane and probed using α-Rev31–50 antibodies. The same amount of HeLa cell extract prior to immunoprecipitation was used as input control in western blot assays.
Expression and purification of the recombinant GST/RG- protein in E. coli
E. coli XL1 Blue cells transformed with pGST/RG- were induced or not overnight with 0.5 mM IPTG and lysed using lysis buffer (50 mM Tris-Cl pH 8.0, 1 mM EDTA, 100 mM NaCl and 1 mg/ml of lysozyme). The recombinant protein was purified using a glutathione-Sepharose 4B column (MicroSpin™ GST Purification Module, Amersham) following the manufacturer's instructions. The recombinant protein was verified by SDS-PAGE and by immunoblotting with α-GST (Amersham) or α-GST/RG- polyclonal antibodies.
Determination of NF90 RG-/Rev interaction by affinity chromatography
After binding the GST/RG- protein to the glutathione-Sepharose 4B column, extracts from 106 HeLa cells transfected with pRSV/Rev, or 15 μg of purified Rev protein  [obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, and NIAID, NIH: HIV-1 (wild type) from D. Rekosh, M.-L. Hammarskjöld, and M. Orsini] were added to the column. After several washes to remove unbound protein, the GST/RG-:Rev protein complex was eluted and analyzed by SDS-PAGE and the proteins detected by Coomassie staining.
To determine if NF90ctv influences the cellular localization of Rev, HeLa cells (8 × 104) were co-transfected either with 1 μ pRev/mRFP alone, with 1 μ pRev/mRFP + 1 μ pGFP/NF90 or with 1 μ pGFP/NF90 alone; 1 μ pmRFP was used as negative control. After 24 h, the cells were fixed for 20 min with 2% paraformaldehyde at room temperature. Following three washes with 1 × PBS, the nuclei were stained with 4-6-diamidino-2-phenylindol (DAPI), the cells were mounted with Citifluor (Canterbury, UK) and the GFP or mRFP was detected using a Leica SP2 AOBS confocal microscope with a 63×, 1.32NA PlanApo lens using an Argon laser (488 nm) or a Krypton laser (568 nm), respectively. The images were assembled using Adobe PhotoShop.
To study the effect of leptomycin B (LMB) on the subcellular localization of Rev and NF90ctv, HeLa cells were co-transfected as described above, and 24 h later, 50 ng/ml of LMB were added and incubation continued for 2 h at 37°C in 5% CO2. The cells were then fixed following the procedure described above and observed using a Leica SP2 AOBS confocal microscope.
To examine if NF90 is able to bind the RRE RNA, the HeLa cells were transfected with either 1 μ pRev/mRFP alone or with 0.4 μ pSGT-5(SDM/RRE/CM-GFP) or with 1 μ pNF90/mRFP with or without 0.4 μ pSGT-5(SDM/RRE/CM-GFP). As negative control, we used the HeLa cells trasnfected only with pSGT-5(SDM/RRE/CM-GFP). After 24 h, the GFP or mRFP was detected by confocal microscopy, as described above.
We are grateful to Xiomara Usuga for purified GST/ and α-GST/RG- serum, Anne-Lise Haenni for revision of manuscript, Myriam Barre and Juan C Hernández for their helped draft in the figures, and to the NIH AIDS Research and Reference Reagent Program for the donation of reagents. This study was supported by the Foundation for the Promotion of Research and Technology, grant Number1.342 (Banco de la República-Colombia) and by the CNRS UMR 7592 to DH-V.
- 15.Saunders LR, Perkins DJ, Balachandran S, Michaels R, Ford R, Mayeda A, Barber GN: Characterization of two evolutionarily conserved, alternatively spliced nuclear phosphoproteins, NFAR-1 and -2, that function in mRNA processing and interact with the double-stranded RNA-dependent protein kinase, PKR. J Biol Chem. 2001, 276: 32300-32312. 10.1074/jbc.M104207200.CrossRefPubMedGoogle Scholar
- 40.Smulevitch S, Bear J, Alicea C, Rosati M, Jalah R, Zolotukhin AS, von Gegerfelt A, Michalowski D, Moroni C, Pavlakis GN, Felber BK: RTE and CTE mRNA export elements synergistically increase expression of unstable, Rev-dependant HIV and SIV mRNAs. Retrovirology. 2006, 3: 6-15. 10.1186/1742-4690-3-6.PubMedCentralCrossRefPubMedGoogle Scholar
- 43.Soros VB, Carvajal HV, Richard S, Cochrane AW: Inhibition of human immunodeficiency virus type 1 Rev function by a dominant-negative mutant of Sam68 through sequestration of unspliced RNA at perinuclear bundles. J Virol. 2001, 75: 8203-8215. 10.1128/JVI.75.17.8203-8215.2001.PubMedCentralCrossRefPubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.